Table of Content

1 Report Overview
1.1 Influenza Drugs Definition
1.2 Market by Type
1.2.1 Global Influenza Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Zanamivir
1.2.3 Oseltamivir Phosphate
1.2.4 Peramivir
1.2.5 Other Influenza Drugs
1.3 Market Segment by Application
1.3.1 Global Influenza Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Adults
1.3.3 Chidren
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Influenza Drugs Sales
2.1 Global Influenza Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global Influenza Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Influenza Drugs Revenue by Region
2.3.1 Global Influenza Drugs Revenue by Region (2018-2024)
2.3.2 Global Influenza Drugs Revenue by Region (2024-2034)
2.4 Global Influenza Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Influenza Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Influenza Drugs Sales Quantity by Region
2.6.1 Global Influenza Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global Influenza Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Influenza Drugs Sales Quantity by Manufacturers
3.1.1 Global Influenza Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Influenza Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Influenza Drugs Sales in 2022
3.2 Global Influenza Drugs Revenue by Manufacturers
3.2.1 Global Influenza Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Influenza Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Drugs Revenue in 2022
3.3 Global Influenza Drugs Sales Price by Manufacturers
3.4 Global Key Players of Influenza Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Influenza Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Influenza Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Influenza Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Influenza Drugs Sales Quantity by Type
4.1.1 Global Influenza Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Influenza Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global Influenza Drugs Revenue by Type
4.2.1 Global Influenza Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Influenza Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Influenza Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Influenza Drugs Price by Type
4.3.1 Global Influenza Drugs Price by Type (2018-2024)
4.3.2 Global Influenza Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Influenza Drugs Sales Quantity by Application
5.1.1 Global Influenza Drugs Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Influenza Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global Influenza Drugs Revenue by Application
5.2.1 Global Influenza Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Influenza Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global Influenza Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Influenza Drugs Price by Application
5.3.1 Global Influenza Drugs Price by Application (2018-2024)
5.3.2 Global Influenza Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America Influenza Drugs Sales by Company
6.1.1 North America Influenza Drugs Revenue by Company (2018-2024)
6.1.2 North America Influenza Drugs Sales Quantity by Company (2018-2024)
6.2 North America Influenza Drugs Market Size by Type
6.2.1 North America Influenza Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America Influenza Drugs Revenue by Type (2018-2034)
6.3 North America Influenza Drugs Market Size by Application
6.3.1 North America Influenza Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America Influenza Drugs Revenue by Application (2018-2034)
6.4 North America Influenza Drugs Market Size by Country
6.4.1 North America Influenza Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Influenza Drugs Revenue by Country (2018-2034)
6.4.3 North America Influenza Drugs Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Influenza Drugs Sales by Company
7.1.1 Europe Influenza Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe Influenza Drugs Revenue by Company (2018-2024)
7.2 Europe Influenza Drugs Market Size by Type
7.2.1 Europe Influenza Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe Influenza Drugs Revenue by Type (2018-2034)
7.3 Europe Influenza Drugs Market Size by Application
7.3.1 Europe Influenza Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe Influenza Drugs Revenue by Application (2018-2034)
7.4 Europe Influenza Drugs Market Size by Country
7.4.1 Europe Influenza Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Influenza Drugs Revenue by Country (2018-2034)
7.4.3 Europe Influenza Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Influenza Drugs Sales by Company
8.1.1 China Influenza Drugs Sales Quantity by Company (2018-2024)
8.1.2 China Influenza Drugs Revenue by Company (2018-2024)
8.2 China Influenza Drugs Market Size by Type
8.2.1 China Influenza Drugs Sales Quantity by Type (2018-2034)
8.2.2 China Influenza Drugs Revenue by Type (2018-2034)
8.3 China Influenza Drugs Market Size by Application
8.3.1 China Influenza Drugs Sales Quantity by Application (2018-2034)
8.3.2 China Influenza Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Influenza Drugs Sales by Company
9.1.1 APAC Influenza Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC Influenza Drugs Revenue by Company (2018-2024)
9.2 APAC Influenza Drugs Market Size by Type
9.2.1 APAC Influenza Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC Influenza Drugs Revenue by Type (2018-2034)
9.3 APAC Influenza Drugs Market Size by Application
9.3.1 APAC Influenza Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC Influenza Drugs Revenue by Application (2018-2034)
9.4 APAC Influenza Drugs Market Size by Region
9.4.1 APAC Influenza Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Influenza Drugs Revenue by Region (2018-2034)
9.4.3 APAC Influenza Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Influenza Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Influenza Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Influenza Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Influenza Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Influenza Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Influenza Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Influenza Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America Influenza Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Influenza Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Bristol-Myers Squibb]
11.1.1 Bristol-Myers Squibb] Company Information
11.1.2 Bristol-Myers Squibb] Overview
11.1.3 Bristol-Myers Squibb] Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Bristol-Myers Squibb] Influenza Drugs Products and Services
11.1.5 Bristol-Myers Squibb] Influenza Drugs SWOT Analysis
11.1.6 Bristol-Myers Squibb] Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 AstraZeneca Influenza Drugs Products and Services
11.2.5 AstraZeneca Influenza Drugs SWOT Analysis
11.2.6 AstraZeneca Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Eli Lilly Influenza Drugs Products and Services
11.3.5 Eli Lilly Influenza Drugs SWOT Analysis
11.3.6 Eli Lilly Recent Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Overview
11.4.3 Roche Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Roche Influenza Drugs Products and Services
11.4.5 Roche Influenza Drugs SWOT Analysis
11.4.6 Roche Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 GlaxoSmithKline Influenza Drugs Products and Services
11.5.5 GlaxoSmithKline Influenza Drugs SWOT Analysis
11.5.6 GlaxoSmithKline Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Novartis Influenza Drugs Products and Services
11.6.5 Novartis Influenza Drugs SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Pfizer Influenza Drugs Products and Services
11.7.5 Pfizer Influenza Drugs SWOT Analysis
11.7.6 Pfizer Recent Developments
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Company Information
11.8.2 Sanofi Pasteur Overview
11.8.3 Sanofi Pasteur Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Sanofi Pasteur Influenza Drugs Products and Services
11.8.5 Sanofi Pasteur Influenza Drugs SWOT Analysis
11.8.6 Sanofi Pasteur Recent Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Overview
11.9.3 Bayer Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Bayer Influenza Drugs Products and Services
11.9.5 Bayer Influenza Drugs SWOT Analysis
11.9.6 Bayer Recent Developments
11.10 Celgene
11.10.1 Celgene Company Information
11.10.2 Celgene Overview
11.10.3 Celgene Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Celgene Influenza Drugs Products and Services
11.10.5 Celgene Influenza Drugs SWOT Analysis
11.10.6 Celgene Recent Developments
11.11 Seqirus
11.11.1 Seqirus Company Information
11.11.2 Seqirus Overview
11.11.3 Seqirus Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Seqirus Influenza Drugs Products and Services
11.11.5 Seqirus Recent Developments
11.12 Protein Sciences Corporation
11.12.1 Protein Sciences Corporation Company Information
11.12.2 Protein Sciences Corporation Overview
11.12.3 Protein Sciences Corporation Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Protein Sciences Corporation Influenza Drugs Products and Services
11.12.5 Protein Sciences Corporation Recent Developments
11.13 Serum Institute of India
11.13.1 Serum Institute of India Company Information
11.13.2 Serum Institute of India Overview
11.13.3 Serum Institute of India Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Serum Institute of India Influenza Drugs Products and Services
11.13.5 Serum Institute of India Recent Developments
11.14 Emergent Biosolutions
11.14.1 Emergent Biosolutions Company Information
11.14.2 Emergent Biosolutions Overview
11.14.3 Emergent Biosolutions Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Emergent Biosolutions Influenza Drugs Products and Services
11.14.5 Emergent Biosolutions Recent Developments
11.15 BioCryst Pharmaceuticals
11.15.1 BioCryst Pharmaceuticals Company Information
11.15.2 BioCryst Pharmaceuticals Overview
11.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 BioCryst Pharmaceuticals Influenza Drugs Products and Services
11.15.5 BioCryst Pharmaceuticals Recent Developments
11.16 Alvogen
11.16.1 Alvogen Company Information
11.16.2 Alvogen Overview
11.16.3 Alvogen Influenza Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Alvogen Influenza Drugs Products and Services
11.16.5 Alvogen Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Influenza Drugs Value Chain Analysis
12.2 Influenza Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Drugs Production Mode & Process
12.4 Influenza Drugs Sales and Marketing
12.4.1 Influenza Drugs Sales Channels
12.4.2 Influenza Drugs Distributors
12.5 Influenza Drugs Customers
13 Market Dynamics
13.1 Influenza Drugs Industry Trends
13.2 Influenza Drugs Market Drivers
13.3 Influenza Drugs Market Challenges
13.4 Influenza Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Influenza Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Zanamivir
Table 3. Major Manufacturers of Oseltamivir Phosphate
Table 4. Major Manufacturers of Peramivir
Table 5. Major Manufacturers of Other Influenza Drugs
Table 6. Global Influenza Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Influenza Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Influenza Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Influenza Drugs Revenue Market Share by Region (2018-2024)
Table 10. Global Influenza Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Influenza Drugs Revenue Market Share by Region (2024-2034)
Table 12. Global Influenza Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 13. Global Influenza Drugs Sales by Region (2018-2024) & (K MT)
Table 14. Global Influenza Drugs Sales Market Share by Region (2018-2024)
Table 15. Global Influenza Drugs Sales by Region (2024-2034) & (K MT)
Table 16. Global Influenza Drugs Sales Market Share by Region (2024-2034)
Table 17. Global Influenza Drugs Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 18. Global Influenza Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Influenza Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Influenza Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Influenza Drugs Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Key Players of Influenza Drugs, Industry Ranking, 2021 VS 2022
Table 23. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Influenza Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2022)
Table 25. Global Key Manufacturers of Influenza Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Influenza Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Influenza Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Influenza Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 30. Global Influenza Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 31. Global Influenza Drugs Sales Quantity Share by Type (2018-2024)
Table 32. Global Influenza Drugs Sales Quantity Share by Type (2024-2034)
Table 33. Global Influenza Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Influenza Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Influenza Drugs Revenue Share by Type (2018-2024)
Table 36. Global Influenza Drugs Revenue Share by Type (2024-2034)
Table 37. Influenza Drugs Price by Type (2018-2024) & (USD/MT)
Table 38. Global Influenza Drugs Price Forecast by Type (2024-2034) & (USD/MT)
Table 39. Global Influenza Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 40. Global Influenza Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 41. Global Influenza Drugs Sales Quantity Share by Application (2018-2024)
Table 42. Global Influenza Drugs Sales Quantity Share by Application (2024-2034)
Table 43. Global Influenza Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Influenza Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Influenza Drugs Revenue Share by Application (2018-2024)
Table 46. Global Influenza Drugs Revenue Share by Application (2024-2034)
Table 47. Influenza Drugs Price by Application (2018-2024) & (USD/MT)
Table 48. Global Influenza Drugs Price Forecast by Application (2024-2034) & (USD/MT)
Table 49. North America Influenza Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Influenza Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 51. North America Influenza Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 52. North America Influenza Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 53. North America Influenza Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Influenza Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Influenza Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 56. North America Influenza Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 57. North America Influenza Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Influenza Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Influenza Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Influenza Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Influenza Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Influenza Drugs Sales Quantity by Country (2018-2024) & (K MT)
Table 63. North America Influenza Drugs Sales Quantity by Country (2024-2034) & (K MT)
Table 64. Europe Influenza Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 65. Europe Influenza Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Influenza Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 67. Europe Influenza Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 68. Europe Influenza Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Influenza Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Influenza Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 71. Europe Influenza Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 72. Europe Influenza Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Influenza Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Influenza Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Influenza Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Influenza Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Influenza Drugs Sales Quantity by Country (2018-2024) & (K MT)
Table 78. Europe Influenza Drugs Sales Quantity by Country (2024-2034) & (K MT)
Table 79. China Influenza Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 80. China Influenza Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Influenza Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 82. China Influenza Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 83. China Influenza Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Influenza Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Influenza Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 86. China Influenza Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 87. China Influenza Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Influenza Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Influenza Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 90. APAC Influenza Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Influenza Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 92. APAC Influenza Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 93. APAC Influenza Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Influenza Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Influenza Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 96. APAC Influenza Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 97. APAC Influenza Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Influenza Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Influenza Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Influenza Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Influenza Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Influenza Drugs Sales Quantity by Region (2018-2024) & (K MT)
Table 103. APAC Influenza Drugs Sales Quantity by Region (2024-2034) & (K MT)
Table 104. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Influenza Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 108. Middle East, Africa and Latin America Influenza Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Influenza Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 111. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 112. Middle East, Africa and Latin America Influenza Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Influenza Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Influenza Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Influenza Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Influenza Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Country (2018-2024) & (K MT)
Table 118. Middle East, Africa and Latin America Influenza Drugs Sales Quantity by Country (2024-2034) & (K MT)
Table 119. Bristol-Myers Squibb] Company Information
Table 120. Bristol-Myers Squibb] Description and Overview
Table 121. Bristol-Myers Squibb] Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 122. Bristol-Myers Squibb] Influenza Drugs Product and Services
Table 123. Bristol-Myers Squibb] Influenza Drugs SWOT Analysis
Table 124. Bristol-Myers Squibb] Recent Developments
Table 125. AstraZeneca Company Information
Table 126. AstraZeneca Description and Overview
Table 127. AstraZeneca Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 128. AstraZeneca Influenza Drugs Product and Services
Table 129. AstraZeneca Influenza Drugs SWOT Analysis
Table 130. AstraZeneca Recent Developments
Table 131. Eli Lilly Company Information
Table 132. Eli Lilly Description and Overview
Table 133. Eli Lilly Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 134. Eli Lilly Influenza Drugs Product and Services
Table 135. Eli Lilly Influenza Drugs SWOT Analysis
Table 136. Eli Lilly Recent Developments
Table 137. Roche Company Information
Table 138. Roche Description and Overview
Table 139. Roche Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 140. Roche Influenza Drugs Product and Services
Table 141. Roche Influenza Drugs SWOT Analysis
Table 142. Roche Recent Developments
Table 143. GlaxoSmithKline Company Information
Table 144. GlaxoSmithKline Description and Overview
Table 145. GlaxoSmithKline Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 146. GlaxoSmithKline Influenza Drugs Product and Services
Table 147. GlaxoSmithKline Influenza Drugs SWOT Analysis
Table 148. GlaxoSmithKline Recent Developments
Table 149. Novartis Company Information
Table 150. Novartis Description and Overview
Table 151. Novartis Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 152. Novartis Influenza Drugs Product and Services
Table 153. Novartis Influenza Drugs SWOT Analysis
Table 154. Novartis Recent Developments
Table 155. Pfizer Company Information
Table 156. Pfizer Description and Overview
Table 157. Pfizer Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 158. Pfizer Influenza Drugs Product and Services
Table 159. Pfizer Influenza Drugs SWOT Analysis
Table 160. Pfizer Recent Developments
Table 161. Sanofi Pasteur Company Information
Table 162. Sanofi Pasteur Description and Overview
Table 163. Sanofi Pasteur Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 164. Sanofi Pasteur Influenza Drugs Product and Services
Table 165. Sanofi Pasteur Influenza Drugs SWOT Analysis
Table 166. Sanofi Pasteur Recent Developments
Table 167. Bayer Company Information
Table 168. Bayer Description and Overview
Table 169. Bayer Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 170. Bayer Influenza Drugs Product and Services
Table 171. Bayer Influenza Drugs SWOT Analysis
Table 172. Bayer Recent Developments
Table 173. Celgene Company Information
Table 174. Celgene Description and Overview
Table 175. Celgene Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 176. Celgene Influenza Drugs Product and Services
Table 177. Celgene Influenza Drugs SWOT Analysis
Table 178. Celgene Recent Developments
Table 179. Seqirus Company Information
Table 180. Seqirus Description and Overview
Table 181. Seqirus Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 182. Seqirus Influenza Drugs Product and Services
Table 183. Seqirus Recent Developments
Table 184. Protein Sciences Corporation Company Information
Table 185. Protein Sciences Corporation Description and Overview
Table 186. Protein Sciences Corporation Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 187. Protein Sciences Corporation Influenza Drugs Product and Services
Table 188. Protein Sciences Corporation Recent Developments
Table 189. Serum Institute of India Company Information
Table 190. Serum Institute of India Description and Overview
Table 191. Serum Institute of India Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 192. Serum Institute of India Influenza Drugs Product and Services
Table 193. Serum Institute of India Recent Developments
Table 194. Emergent Biosolutions Company Information
Table 195. Emergent Biosolutions Description and Overview
Table 196. Emergent Biosolutions Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 197. Emergent Biosolutions Influenza Drugs Product and Services
Table 198. Emergent Biosolutions Recent Developments
Table 199. BioCryst Pharmaceuticals Company Information
Table 200. BioCryst Pharmaceuticals Description and Overview
Table 201. BioCryst Pharmaceuticals Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 202. BioCryst Pharmaceuticals Influenza Drugs Product and Services
Table 203. BioCryst Pharmaceuticals Recent Developments
Table 204. Alvogen Company Information
Table 205. Alvogen Description and Overview
Table 206. Alvogen Influenza Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 207. Alvogen Influenza Drugs Product and Services
Table 208. Alvogen Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Influenza Drugs Distributors List
Table 212. Influenza Drugs Customers List
Table 213. Influenza Drugs Market Trends
Table 214. Influenza Drugs Market Drivers
Table 215. Influenza Drugs Market Challenges
Table 216. Influenza Drugs Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs Product Picture
Figure 2. Global Influenza Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Influenza Drugs Market Share by Type in 2022 & 2034
Figure 4. Zanamivir Product Picture
Figure 5. Oseltamivir Phosphate Product Picture
Figure 6. Peramivir Product Picture
Figure 7. Other Influenza Drugs Product Picture
Figure 8. Global Influenza Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Influenza Drugs Market Share by Application in 2022 & 2034
Figure 10. Adults
Figure 11. Chidren
Figure 12. Influenza Drugs Report Years Considered
Figure 13. Global Influenza Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Influenza Drugs Revenue 2018-2034 (US$ Million)
Figure 15. Global Influenza Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Influenza Drugs Sales Quantity 2018-2034 (K MT)
Figure 17. Global Influenza Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Influenza Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Influenza Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 20. North America Influenza Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Influenza Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. Europe Influenza Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Influenza Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. China Influenza Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Influenza Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. APAC Influenza Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Influenza Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. Middle East, Africa and Latin America Influenza Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Influenza Drugs Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Influenza Drugs Revenue in 2022
Figure 31. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Influenza Drugs Revenue Market Share by Type (2018-2034)
Figure 34. Global Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Influenza Drugs Revenue Market Share by Application (2018-2034)
Figure 36. North America Influenza Drugs Revenue Market Share by Company in 2022
Figure 37. North America Influenza Drugs Sales Quantity Market Share by Company in 2022
Figure 38. North America Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Influenza Drugs Revenue Market Share by Type (2018-2034)
Figure 40. North America Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Influenza Drugs Revenue Market Share by Application (2018-2034)
Figure 42. North America Influenza Drugs Revenue Share by Country (2018-2034)
Figure 43. North America Influenza Drugs Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Influenza Drugs Sales Quantity Market Share by Company in 2022
Figure 47. Europe Influenza Drugs Revenue Market Share by Company in 2022
Figure 48. Europe Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Influenza Drugs Revenue Market Share by Type (2018-2034)
Figure 50. Europe Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Influenza Drugs Revenue Market Share by Application (2018-2034)
Figure 52. Europe Influenza Drugs Revenue Share by Country (2018-2034)
Figure 53. Europe Influenza Drugs Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. France Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 59. China Influenza Drugs Sales Quantity Market Share by Company in 2022
Figure 60. China Influenza Drugs Revenue Market Share by Company in 2022
Figure 61. China Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Influenza Drugs Revenue Market Share by Type (2018-2034)
Figure 63. China Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Influenza Drugs Revenue Market Share by Application (2018-2034)
Figure 65. APAC Influenza Drugs Sales Quantity Market Share by Company in 2022
Figure 66. APAC Influenza Drugs Revenue Market Share by Company in 2022
Figure 67. APAC Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Influenza Drugs Revenue Market Share by Type (2018-2034)
Figure 69. APAC Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Influenza Drugs Revenue Market Share by Application (2018-2034)
Figure 71. APAC Influenza Drugs Revenue Share by Region (2018-2034)
Figure 72. APAC Influenza Drugs Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. India Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Influenza Drugs Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Influenza Drugs Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Influenza Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Influenza Drugs Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Influenza Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Influenza Drugs Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Influenza Drugs Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Influenza Drugs Revenue Share by Country (2018-2034)
Figure 86. Brazil Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Influenza Drugs Revenue (2018-2034) & (US$ Million)
Figure 91. Influenza Drugs Value Chain
Figure 92. Influenza Drugs Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed